This article is more than 5 years old. Information may no longer be current.
IRIS Registry provides meaningful data to ophthalmic practices
Click Here to Manage Email Alerts
CHICAGO — More than 5,000 U.S. ophthalmologists are now participating in the IRIS Registry, comprising data from 10 million patient visits, according to a press release issued by the American Academy of Ophthalmology at its annual meeting here.
Launched less than 1 year ago, the IRIS (Intelligent Research in Sight) Registry is a centralized data repository and reporting tool for the aggregation of patient data from electronic health records for statistical analysis.
The registry’s aim is to help reduce costs, improve the speed of clinical trials, assist with monitoring the use of resources and enable compliance with federal incentive programs.
“The IRIS Registry is proving to be a revolutionary tool that Academy member physicians are embracing as a catalyst for improving the quality of care we can provide to our patients,” David W. Parke II, MD, CEO of the AAO, said in a press release. “Ophthalmologists are now able to harness the power of many millions of pieces of clinical information in order to make evidence-based patient-care analyses that were not previously possible.”
The AAO released the following data generated from the IRIS Registry:
- Two percent of patients without comorbidities require an additional procedure for complications within 30 days after cataract surgery (not including YAG laser).
- Eighty percent of patients without comorbidities have 20/30 vision or better within 90 days after cataract surgery.
- Ten percent of patients have age-related macular degeneration.
- Forty-six percent of patients with AMD receive counseling about antioxidants when seen by an ophthalmologist.
- Eleven percent of all patients have primary open-angle glaucoma.
- Six percent of all patients in the IRIS Registry have diabetic retinopathy.
“Within a very short amount of time, ophthalmology practices are already making meaningful improvements in patient care, based on information gleaned from IRIS Registry data,” William L. Rich III, MD, medical director of health policy for the AAO, said in the release. “As the database continues to grow, our profession will have a wealth of statistically relevant data that will fill many gaps in ophthalmic knowledge to improve the overall quality of patient care.”